Literature DB >> 19955949

Vaginectomy: a minimally invasive treatment for cervical cancer vaginal recurrence.

Pierluigi Benedetti Panici1, Natalina Manci, Filippo Bellati, Violante Di Donato, Claudia Marchetti, Carmen De Falco, Chiara Di Tucci, Roberto Angioli.   

Abstract

OBJECTIVE: Radiotherapy and/or pelvic exenteration represent the treatment of vaginal recurrence, but the prognosis remains unsatisfactory and with long-term complications. We investigated the possible role of vaginectomy for isolated vaginal relapse (IVR) in cervical cancer (CC).
METHODS: Patients with vaginal CC recurrence were evaluated for surgical treatment consisting in vaginectomy. Data were prospectively collected and analyzed to identify independent prognostic factors.
RESULTS: Twenty-nine patients with IVR from CC were enrolled. Early and late complications were observed in 7 (24%) and 6 (21%) patients, respectively. After a median follow-up of 57.5 months (range, 8-100 months), 16 patients (55%) were disease-free. The 5-year overall survival and progression-free survival rates were 70.5% and 59.4%, respectively.
CONCLUSIONS: In carefully selected patients, vaginectomy may be considered a therapeutic option for IVR. Older patients with long disease-free interval and small recurrences benefit the most from this bladder-sparing surgical technique.

Entities:  

Mesh:

Year:  2009        PMID: 19955949     DOI: 10.1111/IGC.0b013e3181a80a0a

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  5 in total

1.  Is a Vaginectomy Enough or is a Pelvic Exenteration Always Required for Surgical Treatment of Recurrent Cervical Cancer? A Propensity-Matched Study.

Authors:  Giuseppe Vizzielli; Lucia Tortorella; Carmine Conte; Vito Chiantera; Valerio Gallotta; Nazario Foschi; Martina Arcieri; Gabriella Ferrandina; Anna Fagotti; Filiberto Zattoni; Giovanni Scambia; Alfredo Ercoli
Journal:  Ann Surg Oncol       Date:  2020-10-15       Impact factor: 5.344

2.  Resection of the vaginal vault for vaginal recurrence of cervical cancer after hysterectomy and brachytherapy.

Authors:  Akiko Abe; Maki Matoda; Sanshiro Okamoto; Eiji Kondo; Kazuyoshi Kato; Kohei Omatsu; Kenji Umayahara; Kuniko Utsugi; Nobuhiro Takeshima
Journal:  World J Surg Oncol       Date:  2015-04-02       Impact factor: 2.754

3.  Hyperprogressive Disease In Cervical Small Cell Carcinoma Treated By Immune Checkpoint Inhibitor.

Authors:  Zihan Xu; Liying Chen; Linpeng Zheng; Qiao Yang; Mingjing Chen; Jianmin Wang; Guangkuo Zhu; Zhengtang Chen; Jianguo Sun
Journal:  Onco Targets Ther       Date:  2019-10-30       Impact factor: 4.147

4.  Laterally Extended Endopelvic Resection Versus Chemo or Targeted Therapy Alone for Pelvic Sidewall Recurrence of Cervical Cancer.

Authors:  Soo Jin Park; Jaehee Mun; Seungmee Lee; Yanlin Luo; Hyun Hoon Chung; Jae-Weon Kim; Noh Hyun Park; Yong Sang Song; Hee Seung Kim
Journal:  Front Oncol       Date:  2021-05-25       Impact factor: 6.244

5.  First case of isolated vaginal metastasis from breast cancer treated by surgery.

Authors:  Filippo Bellati; Innocenza Palaia; Maria Luisa Gasparri; Angela Musella; Pierluigi Benedetti Panici
Journal:  BMC Cancer       Date:  2012-10-17       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.